MSMichael Shterenshis

Michael Shterenshis

*This is an algorithmically generated author record based on publicly available information.

Michael Shterenshis has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Immediate mental health status of refugees during the Ukrainian armed conflict of 2022.

    by Yulia Roitblat, Liliia Nehuliaieva, Roksolana Nedilko, Yurii Shashkov, Michael Shterenshis

    The study assessed stressors and the immediate mental health status of the Ukrainian refugees during the ongoing Ukrainian armed conflict of 2022 and analyzed strategies for reducing anxiety levels. The questionnaire-based prospective study was undertaken in Lviv, Ukraine (five study groups) and Israel (two groups) among 27,901 refugees and 1,259 controls. We assessed the levels of anxiety with General Anxiety Disorder-7 (GAD-7; score range = 0-21, mild to severe) and Refugees' Anxiety Reasons-6 (RAR-6) with a score ranging from 30 (no anxiety) to 6 (extreme anxiety) questionnaires. RAR-6 assessed worries about personal safety, money matters, relatives under fire, the future of the country, limited medications, and general mental fatigue. The study involved refugees in the migration phase and internally displaced persons. The GAD-7 score of 16.1 +/- 2.6 (severe anxiety) showed that all participants experienced anxiety during current hostilities. The RAR-6 score of 21.8 +/- 1.7 demonstrated that participants worried about numerous acute problems, but the results varied from group to group. The refugees who moved abroad independently and without a clear goal had the worst GAD-7 score of 19.4 +/- 1.7. The refugees who traveled abroad in a group-organized manner had the best RAR-6 score of 24.8 +/- 1.5, while passing through Lviv refugees had the worst RAR-6 score of 19.0 +/- 1.6 (p = .03). During hostilities, refugees, internally displaced persons, and regular inhabitants are mentally affected to varying degrees. For refugees, group-organized travel abroad is the best option to maintain adequate mental health, followed by an internal refugee status and traveling abroad independently (the worst strategy).


  • Adolescents’ knowledge regarding Alzheimer’s disease is declining: An international study

    by Yulia Roitblat, Elijah Faridnia, Antony Morgan, Liliia Nehuliaieva, Kadri Mametov, Nigora Z. Nazarova, Michael Shterenshis


  • Immediate physical needs of refugees during the Ukrainian armed conflict of 2022

    by Yulia Roitblat, Liliia Nehuliaieva, Roksolana Nedilko, Yurii Shashkov, Michael Shterenshis


  • Influence of Inosine on Cerebral Hemodynamics in Space Motion Sickness in Experimental Animals

    by Asie N. Useinova, Vitalii B. Kaliberdenko, Igor D. Sapegin, Shanmugaraj Kulanthaivel, Michael V. Shterenshis, Maria I. Dmitriyevskaya, Keerthanaa Balasundaram

    Background: Motion sickness occurs worldwide in healthy individuals regardless of age, ethnicity, or gender. It is an acute disorder; it can also present as a chronic disorder in some individuals. Motion sickness not only includes vomiting and nausea, but also includes other features such as pallor of varying degrees, cold sweating, headache, drowsiness, increased salivation, and cranial pain, which are severe. Some of the other assessment scales can interpret sickness on exposure to virtual or visual stimulation and while travelling in different types of transport. Aim: The aim of our research is to study the effect of the drug on the level of blood flow and vascular reactivity of cerebral vessels when simulating changes in the cerebral circulation in terrestrial conditions characteristic of hypogravity. Methods: Chronic experiments were performed on non-anesthetized rabbits with large hemispheres, thalamus and hypothalamus were implanted with the needle-platinum electrodes 150 mm in diameter in the cortex, and local blood flow and vascular reactivity were recorded accordingly. Cerebrovascular disturbances were modeled using an MSAOP (motion sickness of animals in the anti-orthostatic position) with an inclined angle of 45° for 2 hours. Local blood flow (BF) was measured in ml/min/100g of tissue by the method of registration of hydrogen clearance. The vasodilator coefficient of reactivity (CrCO2) was calculated by the ratio of BF against the background of inhalation of a mixture of 7% CO2 with air to the initial BF; vasoconstrictor - in relation to BF on the background of inhalation of 100% O2 to the initial BF (CrO2). A series of experiments were carried out with different routes of drug administration: First, inosine was administered intravenously at a dose of 5 mg/kg immediately before the start of SMS modeling, same dose was administered 30 minutes before the start of exposure. As a control, we used the results of experimental animals under similar conditions without the administration of the drugs. Results: Inosine has pronounced protective properties in cerebrovascular disorders on the background of space motion sickness (SMS) modeling, which is manifested by normalization of BF and restoration of compensatory reactions of cerebral vessels. In the mechanism of cerebroprotective action of inosine, it is able to correct the metabolic processes, which play an important role and help increase the compensatory capabilities and functional stability of the cerebrovascular system under gravitational influences. Conclusion: When using inosine orally, the effects are more pronounced than when administered intravenously, which should be taken into account when using it for the prevention of cerebrovascular disorders in extreme conditions.

  • The surgical management of the cavity and bone defects in enchondroma cases: A prospective randomized trial

    by Nigora Z. Nazarova, Gulrukh Sh Umarova, Michael Vaiman, Saodat U. Asilova, Michael Abba, Maya Foonberg, Michael Shterenshis


  • Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review

    by Shanmugaraj Kulanthaivel, Vitalii B. Kaliberdenko, Keerthanaa Balasundaram, Michael V. Shterenshis, Emidio Scarpellini, Ludovico Abenavoli

    Introduction: Coronavirus is a group of viruses which causes diseases in mammals and birds. In humans, these family of viruses can cause the respiratory infections from mild form to fatal forms. It is preferably called as coronavirus. Formally it known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or 2019 novel coronavirus (2019- nCoV) and this disease is called as coronavirus disease 2019 (COVID-19). SARS-CoV-2 is infectious in humans and world health organization has announced that Covid-19 as a pandemic disease. Tocilizumab is a biological agent which inhibits the cytokine, interleukin 6 (IL-6 inhibitor). As SARS-CoV-2 infection leads to the development of cytokine storm syndrome, the drug tocilizumab seems to have positive effect in patients with covid-19. Purpose of the Study: To analyze and review the possible effects and efficacy of the tocilizumab (monoclonal antibody against IL-6 receptors) in SARS-CoV-2 patients. Materials and methods: The search strategy on recent research and review articles is used for the SARS-CoV-2 disease and their characteristics. Furthermore we have analyzed most recent research article on monoclonal antibody against IL-6 receptors (tocilizumab) and their possible clinical effects in Covid-19 and their clinical trials on Covid-19 patients. Results and Conclusion: Covid-19 is a disease caused by SARS-CoV-2 infection. It is a life threatening condition which can give rise to fatal outcomes if left untreated. However there are no approved treatment for covid-19 globally. Furthermore we can conclude that SARS-CoV-2 is associated with worsening of lung conditions characterized by interstitial pneumonia with acute respiratory distress syndrome as a result of cytokine storm syndrome. According to available research data tocilizumab, a recombinant humanized anti-human monoclonal antibody of IgG1τ (gamma 1, kappa) can improve patient’s condition from cytokine storm syndrome by inhibiting the IL-6 (Interleukin 6) receptors. The rational use of the tocilizumab in severe and critically ill covid-19 patients can prevent the development of irreversible lung injury and death of the patient. Three retrospective studies of Xiaoling Xu et al., Pan luo et al. and Paola Tonaiti et al. has shown the efficacy of tocilizumab in severe and critically ill covid-19 patients. However we need more randomized research studies with significant number of patients which can confirm the promising results on tocilizumab treatment in covid-19 patients and even ongoing clinical trails such as TOSCA, COVACTA results has not been published yet which are expected to give better and more significant results on tocilizumab’s effectiveness and safety.


  • Thermal Comfort in School Classes in the Era of Global Warming: A Prospective Multicenter Study

    by Taylor Golshan, Sarah Lande, Kaitlyn Nickfardjam, Sabrina Cohensedgh, Yulia Roitblat, Liliia Nehuliaieva, David Khabie, Ruby Stillman, Anna Volynsky‐Lauson, Kadri Mametov, et al.

    BACKGROUND: We investigated adolescents' feelings of thermal comfort during the educational process in various geographical locations far apart and present recommendations for the adjustment of the thermal environment in schools.METHODS: The prospective international multicenter study took place in 8 locations on different continents. The survey in the form of a questionnaire was carried out among 2800 healthy high school students. The study was divided into “cold season survey,” “warm‐season survey,” and heat wave survey.RESULTS: The statistically significant difference between the “cold season survey” score of 4.04 (discomfort) and “warm‐season survey” score of 3.47 (slight discomfort) (p = .04) indicates that students feel more thermal discomfort during winter months in all 8 locations. The heat wave survey score was 4.53 (discomfort). During the cold season, 29.24% of high school students felt themselves in full thermal comfort and 76.48% of the students felt themselves relatively comfortable (slightly cool—comfortable—slightly warm).CONCLUSIONS: Even during the ongoing process of climate change, the cold season discomfort remains the main problem for students in classes. This tendency is present in different continents as a universal problem. We recommend keeping an entrance hall and classroom temperatures at different levels and to advise students about proper clothing.


  • Owls and larks do not exist: COVID-19 quarantine sleep habits

    by Orit Rome, Leor Sinai, Rachelle Sevitt, Ayela Meroody, Marnie Nadolne, Philip Shilco, Geoffrey P. Jacobs, Michael Shterenshis, Abby Sosnow, Maya Foonberg, et al.


  • Reassessment of Pediatric Tension-Type Headaches

    by Michael Vaiman, Kadri Mametov, Yulia Roitblat, Michael Abba, Liliia Nehuliaieva, Maya Foonberg, Charles Frank, Vitalii B. Kaliberdenko, Michael Shterenshis

    A retrospective multicenter chart review was conducted with the objective of evaluating the hypothesis that certain cases diagnosed as tension-type headache (TTH) in pediatric neurology are not stress-related or central sensitization-related conditions but may mimic an autoimmune disorder of the dura mater. Of the 29,642 patient charts reviewed, 12,424 charts (42%) were excluded because of incomplete data and 17,218 cases were analyzed. For all the 29,642 charts, TTH or chronic daily headaches were diagnosed in 29.2% of cases. Among the 17,218 cases subjected to detailed diagnostic procedures, TTH was diagnosed in only 5%. In 7,044 cases, the initial diagnosis of TTH was changed to headache attributed to infection (87.4%), which was supported by the presence of meningeal signs, high antistreptolysin-O titers, and, in 46% of cases, magnetic resonance imaging (MRI)-detected thickening of the cranial dura mater. The initial diagnosis of migraine was confirmed in 87.7% of cases (8,034/9,162). In some cases of treatment-resistant pediatric recurrent headaches, which are initially diagnosed as TTH, a secondary type of headache may be suspected as the underlying cause. Usually this type of headache has streptococcal infection-related laboratory findings, the meninges as the site of the lesion, and meningism as the clinical presentation.

  • Stay-at-home circumstances do not produce sleep disorders: An international survey during the COVID-19 pandemic

    by Yulia Roitblat, Jacob Burger, Aidan Leit, Liliia Nehuliaieva, Gulrukh Sh. Umarova, Vitalii Kaliberdenko, Shanmugaraj Kulanthaivel, Noa Buchris, Michael Shterenshis